Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE

v3.23.3
NET LOSS PER SHARE
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
NET LOSS PER SHARE NET LOSS PER SHARE
Presented in the table below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share (“EPS”) calculations for the periods ended:
Three Months Ended Nine Months Ended
September 30, September 30,
($ in thousands, except share and per share amounts) 2023 2022 2023 2022
Numerator:
Net loss $ (95,361) $ (14,277) $ (133,350) $ (36,639)
Net loss attributable to common stockholders $ (95,361) $ (14,277) $ (133,350) $ (36,639)
Denominator:    
Weighted average common shares outstanding    
Basic and diluted (in number) 86,655,279  76,240,530  81,046,880  75,514,986 
Net loss per share    
Basic and diluted $ (1.10) $ (0.19) $ (1.65) $ (0.49)

The following securities were not included in the computation of weighted-average diluted shares outstanding because the effect would be anti-dilutive:
Three Months Ended Nine Months Ended
(Number of shares) September 30, September 30,
2023 2022 2023 2022
Common stock issued under the backstop agreement 9,600,031  9,600,031  9,600,031  9,600,031 
Grants of unvested restricted stock units (time-vesting only) 7,449,932  3,840,501  6,021,748  3,468,900 
Private placement warrants 272,779  272,779  272,779  272,779 
Unvested restricted stock units with both time and performance metrics are excluded from the disclosure of weighted-average potentially anti-dilutive securities because the performance metrics were not met at the end of the reporting period; therefore, these securities are not considered to be contingently issuable for purposes of dilutive EPS or anti-dilution calculations.